20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is DOXYCYCLINE USP, with a corresponding US DMF Number 25062.
Remarkably, this DMF maintains an Active status since its submission on June 16, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 10, 2021, and payment made on August 06, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II